A PricewaterhouseCoopers report urges pharmaceutical firms to shift more of their spending from marketing to research because the industry's current business model "is both economically unsustainable and operationally incapable" of moving quickly to produce new treatments demanded by global markets. The report also predicts the emergence of a single global regulatory system by 2020.

Related Summaries